Heart Failure Treatment and Management
Heart failure is a clinical syndrome in which the heart cannot pump enough blood to meet the body's demands, affecting tens of millions of people worldwide and accounting for a disproportionate share of hospitalizations, healthcare costs, and cardiovascular deaths. Researchers in this area work to refine how the condition is diagnosed—including through biomarkers like B-type natriuretic peptide, which rises in the blood when the heart is under strain—and how treatment guidelines can be applied across patients who often carry multiple complicating conditions such as impaired kidney function. A persistent challenge is reducing hospital readmission rates, which remain stubbornly high even after decades of guideline development, pushing investigators to build better risk prediction models that can identify vulnerable patients before they deteriorate. Active work also focuses on understanding why outcomes differ so sharply across populations and how interventions can be tailored to close those gaps.
- Works
- 104,318
- Total citations
- 1,978,001
- Keywords
- Heart FailureGuidelinesDiagnosisTreatmentB-Type Natriuretic PeptideEpidemiology
Top papers in Heart Failure Treatment and Management
Ordered by total citation count.
- Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.↗ 19,548
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure↗ 13,296OA
- 2013 ACCF/AHA Guideline for the Management of Heart Failure↗ 12,638OA
- Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?↗ 11,736
- K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification↗ 11,659
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure↗ 11,557OA
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure↗ 9,143OA
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients↗ 8,671OA
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure↗ 8,068OA
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes↗ 7,484OA
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC↗ 6,914OA
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure↗ 6,899OA
Active researchers
Top authors in this area, ranked by h-index.